Origin Therapeutics Holdings (XCNQ:ORIG) Asset Impairment Charge : C$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Asset Impairment Charge?

Origin Therapeutics Holdings's Asset Impairment Charge for the three months ended in Jun. 2023 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings Asset Impairment Charge Historical Data

The historical data trend for Origin Therapeutics Holdings's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Asset Impairment Charge Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Asset Impairment Charge

0.20

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Asset Impairment Charge	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Origin Therapeutics Holdings Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.